Business Review Cost of goods sold Group balance sheet Cost of goods sold increased by $109m to $1,140m from $1,031m in The following table sets out certain balance sheet data as at 2010 which represents an 11% increase.
Of this movement, 4% is due 31December of the years indicated: to adverse translation movements leaving an underlying movement of 2011 2010 7% compared to an increase in underlying revenue of 4%.
The residual $ million $ million movement is largely attributable to continued pricing pressure across all of the Groups markets which Smith & Nephew was not able to pass on Non-current assets 2,542 2,579 to suppliers and an adverse movement in the mix of products sold, Current assets 2,080 2,154 towards lower gross margin product.
Assets held for sale 125 Further margin analysis is included within the Trading profit sections of the individual business segments that follow on pages 30 to 40.
Total assets 4,747 4,733 Non-current liabilities 422 1,046 Marketing, selling and distribution expenses Marketing, selling and distribution expenses increased by $112m 8% Current liabilities 1,119 914 to $1,526m from $1,414m in 2010.
After adjusting for an unfavourable Liabilities directly associated with assets currency movement of 3% the underlying movement of 5% is broadly in 19 held for sale line with increased Group revenues.
Total liabilities 1,560 1,960 Administrative expenses Total equity 2,773 3,187 Administrative expenses increased by $129m 29% to $575m from Total equity and liabilities 4,747 4,733 $446m in 2010.
Unfavourable currency movements contributed towards 5% of this increase.
The factors contributing to the underlying movement of 24% were: the non-recurrence of the one-off benefit of Non-current assets $25m arising from the BlueSky settlement in 2010, a charge of $23m Non-current assets decreased by $37m to $2,542m in 2011 from relating to legal provision, an increase of $21m in restructuring and $2,579m in 2010.
This is attributable to the following: rationalisation expenses, an increase of $12m in the bad debt expense Goodwill decreased by $5m from $1,101m in 2010 to $1,096m in and an $8m increase in the amortisation charge on intangible assets.
Goodwill totalling $37m was transferred to assets held for Other factors contributing to this increase included the additional sale.
Following the acquisition of Tenet Medical Engineering during investment in China and Emerging Markets during the year.
2011, an amount of $44m was capitalised as goodwill.
The balance relates to unfavourable currency movements totalling $12m.
Research and development expenses Expenditure as a percentage of revenue increased by 0.1% to 3.9% in Intangible assets decreased by $3m from $426m in 2010 to $423m 2011 2010 3.8%.
Actual expenditure was $167m in 2011 compared in 2011.
Intangible assets totalling $14m were transferred to assets to $151m in 2010.
The Group continues to invest in innovative held for sale.
Amortisation of $78m was charged during the year technologies and products to differentiate it from competitors.
and assets with a net book value of $2m were written-off.
A total of $92m relates to the addition of intellectual property and software.
Operating profit The balance relates to unfavourable currency movements totalling$1m.
Operating profit decreased by $58m to $862m from $920m in 2010 comprising a decrease of $88m in Orthopaedics, offset by increases of Property, plant and equipment decreased by $4m from $787m in $18m in Endoscopy and $12m in Advanced Wound Management.
Property, plant and equipment totalling $3m were transferred to assets held for sale.
Depreciation of Net interest payable $217m was charged during 2011 and assets with a net book value Net interest payable reduced by $7m from $15m in 2010 to $8m in of $7m were written-off.
These movements were largely offset by 2011.
This is a consequence of the overall reduction of borrowings $229m of additions relating primarily to instruments and other plant within the Group and a reduction in the applicable interest rates.
The balance relates to unfavourable currency movements totalling $6m.
Other finance cost Trade and other receivables decreased by $22m to $nil in 2011 Other finance costs in 2011 were $6m compared to $10m in 2010.
This from $22m in 2010 due to non-current receivables switching to decrease is attributable to an increase in the expected return on current receivables during the year.
Deferred tax assets and other non-current assets decreased by $3m in the year.
Taxation The taxation charge decreased by $14m to $266m from $280m in 2010.
The effective rate of tax was 31.4%, compared with 31.3% in 2010.
The tax charge was reduced by $17m in 2011 2010 $10m as a consequence of restructuring and rationalisation expenses, amortisation of acquisition intangibles and legal provision.
The effective tax rate was 29.9% 2010 30.8% after adjusting for these items and the tax thereon.
23 Smith & Nephew Annual Report 2011 Accounts and other information Corporate Governance Business Review Strategy, KPIs & Risk management Overview
